IOL Chemicals and Pharmaceuticals Ltd.

IOLCP Stock View

(NSE)

346.30

2,003.33
Proj. ROE (%)
15.25
Proj. P/E (x)
8.95
Proj EV / EBITDA (x)
5.90
Proj. P/BV (x)
1.29
Proj. Revenue ( Cr.)
2,429.65

Stock View

STRONG BUY
Share on
The average score for IOL Chemicals and Pharmaceuticals Ltd. stands at 3 against 7, three months back.

IOL Chemicals and Pharmaceuticals Limited is an India-based generic pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The Company caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. It serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
356.76
100 DMA ()
359.15
200 DMA ()
372.56
52 Weeks Range
292.80
537.20
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp